Hjem › B-celle lymfom › Tennessee › Nashville
Kliniske studier for B-celle lymfom i Nashville, TN
11 studier for B-celle lymfom søker deltakere på steder i og rundt Nashville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
RekruttererFase 1/2
- Sarah Cannon Research Institute, Nashville
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekruttererFase 3
- Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
- Tennessee Oncology, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- SCRI Oncology Partners, Nashville
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Nashville
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
RekruttererFase 3
- SCRI Oncology Partners, Nashville
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
RekruttererFase 1/2
- Research Site, Franklin · 17 mi unna
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
RekruttererFase 1/2
- SCRI Oncology Partners, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Vanderbilt University Medical Center, Nashville
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekruttererFase 3
- Sarah Cannon Research Institute SCRI, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- SCRI Oncology Partners, Nashville
B-celle lymfom-studier i andre byer
- New York City, NY18 studier
- Houston, TX16 studier
- Chicago, IL13 studier
- Philadelphia, PA11 studier
- Rochester, MN10 studier
- Milwaukee, WI9 studier
- Baldwin Park, CA9 studier
- Cleveland, OH9 studier
- Boston, MA8 studier
- Salt Lake City, UT8 studier
- Washington, DC7 studier
- Pittsburgh, PA7 studier
Andre studier i Nashville
- Ikke-småcellet lungekreft97 studier
- Brystkreft81 studier
- Metastatisk kreft70 studier
- Kolorektal kreft69 studier
- Kreft (alle typer)65 studier
- Eggstokkreft49 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Plateepitelcancer i hode og hals39 studier
- Pankreaskreft39 studier
- Endometriekreft38 studier
- Melanom33 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.